GLS Capital

Founded: 2018

Headquarters: Chicago

Number of employees: 11

GLS Capital is a US-based litigation finance firm with more than $500 million under management. Founded by litigation finance industry veterans who have originated, evaluated, and managed hundreds of millions of dollars in litigation finance investments, GLS invests in a wide variety of complex situations dependent upon legal or regulatory risk, specifically across three primary areas: complex commercial litigation and arbitration, patent infringement litigation, and life sciences litigation. Working with law firms and litigants worldwide, with a focus in the United States, GLS invests between $1-$50 million per investment.

GLS Capital prides itself on its decision-making speed and the pace of its investment process. Their unparalleled industry experience also affords unique insights into the evaluation and management of litigation finance investments. Armed with a broad investment mandate, all investment decisions are made internally by the GLS investment committee, which provides certainty and transparency for counterparties throughout the investment lifecycle.

Complex Commercial Litigation & Arbitration Finance:

GLS devotes a considerable portion of its portfolio to investments relating to complex commercial litigation and arbitration. These generally are business-to-business disputes, with the underlying legal claims involving breach of contract, trade secret misappropriation, competition, tortious interference, insolvency, asset recovery, and investment treaty arbitration, among others. GLS invests with respect to both single cases and portfolios of cases involving complex commercial litigation and arbitration, both in the US and worldwide. David Spiegel, Jeffery Lula, and Mick Biehl lead commercial litigation and arbitration investments.

Patent Infringement Litigation Finance:

GLS Capital also has a particular specialty relating to technology-related patent infringement litigation, led by Adam Gill and Joel Merkin. The firm’s principals have invested in intellectual property-related disputes longer than almost any other litigation finance firm. GLS boasts a deep bench of investment professionals who hold considerable hard science and patent litigation experience, all of whom were formerly patent litigators at elite law firms and Fortune 500 companies.

Life Sciences Litigation Finance:

GLS has expertise in a broad range of litigation-related investments that arise in the life sciences industry. The team is led by Jamison Lynch and Dr. Lauren Rabinovic, and has decades of experience and a comprehensive understanding of the complex supply chain, regulatory, and commercial environments for pharmaceutical, medical device and health care companies.